Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Ciavarella

Showing results (31-40 of 60) with videos related to

Pageof 6
Sort By:
Minerva Cardioangiologica|February 12, 2000
[Venous and arterial thromboembolism: autoimmune syndrome with heparin-induced thrombocytopenia. Unusual severe adverse reaction or the tip of the iceberg?]N Ciavarella, C Sabbà, R Triggiani, et al.
British Journal of Haematology|May 1, 1991
Characterization of the pseudogenic and genic homologous regions of von Willebrand factorG Marchetti, P Patracchini, S Volinia, et al.
La Ricerca in Clinica E in Laboratorio|January 1, 1981
[Sensitivity of reagents used for the determination of activated partial thromboplastin time to defects in the intrinsic mechanism of coagulation]N Ciavarella, S Coccheri, P M Mannucci, et al.
Blood|December 1, 1985
High-resolution analysis of von Willebrand factor multimeric composition defines a new variant of type I von Willebrand disease with aberrant structure but presence of all size multimers (type IC)G Ciavarella, N Ciavarella, S Antoncecchi, et al.
Blood|September 1, 1985
Hemophilia B with inhibitor: molecular analysis of the subtotal deletion of the factor IX geneH J Hassan, A Leonardi, R Guerriero, et al.
Clinical and Laboratory Haematology|January 1, 1984
Evaluation of the effectiveness of DDAVP in surgery and in bleeding episodes in haemophilia and von Willebrand's disease. A study on 43 patientsG Mariana, N Ciavarella, M G Mazzucconi, et al.
Annals of Internal Medicine|July 1, 1990
Low risk for hepatitis C in hemophiliacs given a high-purity, pasteurized factor VIII concentrate. International Study GroupP M Mannucci, K Schimpf, D B Brettler, et al.
Vox Sanguinis|January 1, 1994
Virology of the hepatitis A epidemic in ItalyR H Purcell, P M Mannucci, S Gdovin, et al.
Annals of Internal Medicine|January 1, 1994
Transmission of hepatitis A to patients with hemophilia by factor VIII concentrates treated with organic solvent and detergent to inactivate viruses. The Italian Collaborative GroupP M Mannucci, S Gdovin, A Gringeri, et al.
American Journal of Hematology|March 1, 1989
Evaluation of factor VIII pharmacokinetics in hemophilia-A subjects undergoing surgery and description of a nomogram for dosing calculationsG Longo, A Messori, M Morfini, et al.
Pageof 6

Showing results (31-40 of 60) with videos related to

Sort By:
Pageof 6
Minerva Cardioangiologica|February 12, 2000
[Venous and arterial thromboembolism: autoimmune syndrome with heparin-induced thrombocytopenia. Unusual severe adverse reaction or the tip of the iceberg?]N Ciavarella, C Sabbà, R Triggiani, et al.
British Journal of Haematology|May 1, 1991
Characterization of the pseudogenic and genic homologous regions of von Willebrand factorG Marchetti, P Patracchini, S Volinia, et al.
La Ricerca in Clinica E in Laboratorio|January 1, 1981
[Sensitivity of reagents used for the determination of activated partial thromboplastin time to defects in the intrinsic mechanism of coagulation]N Ciavarella, S Coccheri, P M Mannucci, et al.
Blood|December 1, 1985
High-resolution analysis of von Willebrand factor multimeric composition defines a new variant of type I von Willebrand disease with aberrant structure but presence of all size multimers (type IC)G Ciavarella, N Ciavarella, S Antoncecchi, et al.
Blood|September 1, 1985
Hemophilia B with inhibitor: molecular analysis of the subtotal deletion of the factor IX geneH J Hassan, A Leonardi, R Guerriero, et al.
Clinical and Laboratory Haematology|January 1, 1984
Evaluation of the effectiveness of DDAVP in surgery and in bleeding episodes in haemophilia and von Willebrand's disease. A study on 43 patientsG Mariana, N Ciavarella, M G Mazzucconi, et al.
Annals of Internal Medicine|July 1, 1990
Low risk for hepatitis C in hemophiliacs given a high-purity, pasteurized factor VIII concentrate. International Study GroupP M Mannucci, K Schimpf, D B Brettler, et al.
Vox Sanguinis|January 1, 1994
Virology of the hepatitis A epidemic in ItalyR H Purcell, P M Mannucci, S Gdovin, et al.
Annals of Internal Medicine|January 1, 1994
Transmission of hepatitis A to patients with hemophilia by factor VIII concentrates treated with organic solvent and detergent to inactivate viruses. The Italian Collaborative GroupP M Mannucci, S Gdovin, A Gringeri, et al.
American Journal of Hematology|March 1, 1989
Evaluation of factor VIII pharmacokinetics in hemophilia-A subjects undergoing surgery and description of a nomogram for dosing calculationsG Longo, A Messori, M Morfini, et al.
Pageof 6